Health Canada – 2014-2015 – Supplementary Information Tables – Departmental Performance Report

Table of Contents

• Departmental Sustainable Development Strategy
  1. Overview of the Federal Government's Approach to Sustainable Development
  2. Themes I to III: Department-Led Targets
  3. Themes I to III: Implementation Strategies and Clean Air Agenda Financial Table
  4. Theme IV: Targets and Implementation Strategies
  5. Sustainable Development Management System
  6. Strategic Environmental Assessment
• Details on Transfer Payment Programs of $5 Million or More
  • Contributions for First Nations and Inuit Health Infrastructure Support (Voted)
  • Contributions for First Nations and Inuit Primary Health Care (Voted)
  • Contributions for First Nations and Inuit Supplementary Health Benefits (Voted)
  • Territorial Health Investment Fund (Voted)
  • Anti-Drug Strategy Initiatives (Voted)
  • Canada Brain Research Fund to Advance Knowledge for the Treatment of Brain Disorders (Voted)
  • Canadian Blood Services: Blood Research and Development Program (Voted)
  • Contribution to the Canadian Agency for Drugs and Technologies in Health (Voted)
  • Contribution to the Canadian Institute for Health Information (Voted)
  • Contribution to the Canadian Partnership Against Cancer (Voted)
  • Contribution to the Canadian Patient Safety Institute (Voted)
  • Grant to support the Mental Health Commission of Canada (Voted)
  • Health Care Policy Contribution Program (Voted)
  • Official Languages Health Contribution Program (Voted)
  • Thalidomide Survivors Contribution Program (Voted)
• Horizontal Initiatives
  • Federal Tobacco Control Strategy
  • Chemicals Management Plan
• Internal Audits and Evaluations
  • Internal Audits Completed in 2015–16
  • Evaluations in Progress or Completed in 2015–16
• Response to Parliamentary Committees and External Audits
  • Response to Parliamentary Committees
  • Response to the Auditor General (including to the Commissioner of the Environment and Sustainable Development)
  • Response to external audits conducted by the Public Service Commission of Canada or the Office of the Commissioner of Official Languages
• Up-Front Multi-Year Funding
  • Conditional Grant to Canada Health Infoway
  • Conditional Grant to Canadian Foundation for Healthcare Improvement (CFHI)
• User Fees, Regulatory Charges and External Fees
  • Reporting on User Fees Act
    • Fee Rights to Sell Drugs Fee
    • Drug Establishment Licensing Fees
    • Drug Submission Evaluation Fees (Pharmaceuticals and Biologic Products)
    • Medical Device License Application Fees
    • Fee for Right to Sell a Licensed Medical Device
    • Medical Device Establishment Licensing Fees
    • Veterinarian Drug Evaluation Fees
    • Fees charged for filing a claim for exemption under the Hazardous Materials Information Review Act
    • Pest Control Product Application Examination Service
    • Right or Privilege to manufacture or sell a Pest Control Product in Canada and for Establishing a Maximum Residue Limit in relation to a Pest Control Product
    • Fees for processing requests filed under the Access to Information Act
  • Summary of Financial Information for All User Fees and Regulatory Charges
  • Reporting on the Policy on Service Standards for External Fees
    • Fee Rights to Sell Drugs Fee
    • Certificates of Pharmaceutical Product (Drug Export) Fees
    • Drug Establishment Licensing Fees
    • Drug Master File Fees
    • Drug Submission Evaluation Fees (Pharmaceuticals & Biologic Products)
    • Medical Device Licence Application Fees
    • Fees for Right to Sell a Licensed Medical Device
    • Medical Device Establishment Licensing Fees
    • Veterinary Drug Evaluation Fees
    • Fees Charged for filing a claim under the Hazardous Material Information Reviews Act
    • National Dosimetry Services Product (NDSP), Service and Fee Structure (S&F)
    • Fees to be paid for Pest Control Product Application Examination Service
    • Fees to be paid for the right or privilege to manufacture or sell a pest control product in Canada and for establishing a Maximum Residue Limit in relation to a pest control product
    • Fees to be paid for the right of Employee Assistance Services (EAS)